MedX Health Corp MDX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.59% | 67.44% | -26.06% | 47.89% | -16.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.59% | 67.44% | -26.06% | 47.89% | -16.01% |
| Cost of Revenue | 5.08% | 90.27% | 158.10% | 71.98% | 42.22% |
| Gross Profit | 150.39% | 36.75% | -315.30% | 8.00% | -68.41% |
| SG&A Expenses | 26.02% | -22.23% | 265.54% | 97.93% | 22.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.79% | -12.86% | 172.06% | 73.84% | 20.06% |
| Operating Income | -30.53% | 20.28% | -284.94% | -78.66% | -25.16% |
| Income Before Tax | -21.71% | 19.87% | -88.77% | -83.16% | -40.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.71% | 19.87% | -88.77% | -83.16% | -40.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.71% | 19.87% | -88.77% | -83.16% | -40.47% |
| EBIT | -30.53% | 20.28% | -284.94% | -78.66% | -25.16% |
| EBITDA | -30.43% | 19.57% | -285.88% | -80.37% | -25.63% |
| EPS Basic | -6.06% | 34.15% | -62.07% | -63.16% | -26.92% |
| Normalized Basic EPS | -10.00% | 34.62% | -44.44% | -58.33% | -25.00% |
| EPS Diluted | -6.06% | 34.15% | -62.07% | -63.16% | -26.92% |
| Normalized Diluted EPS | -10.00% | 34.62% | -44.44% | -58.33% | -25.00% |
| Average Basic Shares Outstanding | 12.77% | 20.42% | 18.83% | 11.78% | 9.87% |
| Average Diluted Shares Outstanding | 12.77% | 20.42% | 18.83% | 11.78% | 9.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |